MedTrace Logo

First in Human Study of SakuraBead for Genicular Artery Embolization to Treat Pain Secondary to Knee Osteoarthritis

NCT06718478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-12-05

No results posted yet for this study

Summary

A prospective, single-centre, single-arm, unmasked, First in Human study that aims to evaluate the safety and efficacy of SakuraBead resorbable microspheres in adult patients suffering from pain secondary to knee osteoarthritis.

Conditions

  • Osteoarthritis (OA) of the Knee
  • Osteoarthritis Knee Pain
  • Joint Diseases
  • Musculoskeletal Diseases
  • Rheumatic Diseases
  • Arthritis
  • Osteoarthritis

Interventions

DEVICE

SakuraBead Resorbable Microspheres

Temporary Embolization of Genicular Arteries using SakuraBead Resorbable Microspheres

Sponsors & Collaborators

  • CrannMed

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-05
Primary Completion
2024-03-28
Completion
2024-08-23

Countries

  • Uzbekistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06718478 on ClinicalTrials.gov